World Equity Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,155
Closed -$767K 261
2024
Q2
$767K Hold
3,155
0.23% 113
2024
Q1
$472K Buy
3,155
+142
+5% +$23.7K 0.1% 194
2023
Q4
$577K Sell
3,013
-380
-11% -$64.7K 0.12% 176
2023
Q3
$601K Buy
3,393
+333
+11% +$63.5K 0.12% 179
2023
Q2
$581K Sell
3,060
-30,380
-91% -$6.02M 0.17% 154
2023
Q1
$863K Buy
33,440
+30,466
+1,024% +$6.4M 0.13% 183
2022
Q4
$707K Sell
2,974
-31
-1% -$6.61K 0.17% 140
2022
Q3
$601K Sell
3,005
-44
-1% -$8.39K 0.15% 142
2022
Q2
$445K Sell
3,049
-47
-2% -$6.67K 0.11% 200
2022
Q1
$506K Buy
+3,096
New +$472K 0.11% 210

Other funds holding ALNY